VANGUARD GROUP INC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$45,758,469
-0.4%
12,781,695
+2.7%
0.00%0.0%
Q2 2023$45,923,913
+17.5%
12,445,505
+5.4%
0.00%0.0%
Q1 2023$39,096,486
-7.4%
11,811,627
+8.6%
0.00%0.0%
Q4 2022$42,209,197
+87.0%
10,878,659
+17.1%
0.00%0.0%
Q3 2022$22,576,000
+26.1%
9,290,699
+2.8%
0.00%0.0%
Q2 2022$17,899,000
+20.2%
9,040,244
+11.1%
0.00%
Q1 2022$14,893,000
+24.5%
8,138,420
-4.1%
0.00%
Q4 2021$11,963,000
+85.0%
8,484,060
+48.2%
0.00%
Q3 2021$6,467,000
-27.9%
5,723,351
+2.0%
0.00%
Q2 2021$8,975,000
+23.0%
5,609,220
+35.3%
0.00%
Q1 2021$7,297,000
-5.8%
4,146,115
+4.4%
0.00%
Q4 2020$7,743,000
-11.0%
3,971,343
+9.1%
0.00%
Q3 2020$8,702,000
-15.5%
3,640,735
+3.6%
0.00%
Q2 2020$10,293,000
+0.4%
3,512,918
-1.3%
0.00%
Q1 2020$10,253,000
+10.8%
3,560,386
+54.0%
0.00%
Q4 2019$9,250,000
-5.1%
2,312,539
+5.6%
0.00%
Q3 2019$9,746,000
+2.9%
2,190,044
-10.5%
0.00%
Q2 2019$9,474,000
+50.4%
2,448,253
+47.3%
0.00%
Q1 2019$6,298,000
+98.8%
1,661,686
+25.4%
0.00%
Q4 2018$3,168,000
-57.2%
1,325,277
+11.1%
0.00%
Q3 2018$7,406,000
+44.8%
1,192,641
+5.2%
0.00%
Q2 2018$5,115,000
+25.4%
1,134,031
+27.9%
0.00%
Q1 2018$4,080,000
+98.7%
886,987
+38.7%
0.00%
Q4 2017$2,053,000
+113.9%
639,506
+105.3%
0.00%
Q3 2017$960,000
+66.7%
311,514
+107.6%
0.00%
Q2 2017$576,000
-21.3%
150,0280.0%0.00%
Q1 2017$732,000
-1.6%
150,028
+3.2%
0.00%
Q4 2016$744,000
-24.8%
145,394
+6.5%
0.00%
Q3 2016$990,000
+37.5%
136,537
+12.9%
0.00%
Q2 2016$720,000
-25.8%
120,959
+0.8%
0.00%
Q1 2016$971,000
+353.7%
119,959
+354.2%
0.00%
Q4 2015$214,000
-99.8%
26,411
-98.9%
0.00%
-100.0%
Q3 2015$94,155,000
+73458.6%
2,384,633
+17217.6%
0.00%
Q2 2015$128,00013,7700.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders